Evidence map›Paper›PMID 25737740›Full record

ArticleInfectious agents and cancer2015

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs.

Nuttavut Kantathavorn, Chulabhorn Mahidol, Narongrit Sritana, Thaniya Sricharunrat, Natacha Phoolcharoen, Chirayu Auewarakul, Narongchai Teerayathanakul, Chantanee Taepisitpong, Siriporn Saeloo, Gaidganok Sornsamdang and 3 more

Abstract read
In one paragraph

Article in Infectious agents and cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nuttavut KantathavornChulabhorn Hospital, Bangkok, Thailand ; Gynecologic Oncology Unit, Chulabhorn Hospital, 54 Kamphaengphet 6 Road, Laksi, Bangkok, 10210 Thailand.
Chulabhorn MahidolChulabhorn Hospital, Bangkok, Thailand ; Chulabhorn Research Institute, Bangkok, Thailand ; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Narongrit SritanaChulabhorn Hospital, Bangkok, Thailand.
Thaniya SricharunratChulabhorn Hospital, Bangkok, Thailand.
Natacha PhoolcharoenChulabhorn Hospital, Bangkok, Thailand ; Gynecologic Oncology Unit, Chulabhorn Hospital, 54 Kamphaengphet 6 Road, Laksi, Bangkok, 10210 Thailand.
Chirayu AuewarakulChulabhorn Hospital, Bangkok, Thailand ; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Narongchai TeerayathanakulChulabhorn Hospital, Bangkok, Thailand.
Chantanee TaepisitpongChulabhorn Hospital, Bangkok, Thailand.
Siriporn SaelooChulabhorn Hospital, Bangkok, Thailand.
Gaidganok SornsamdangChulabhorn Hospital, Bangkok, Thailand.
Wandee UdomchaiprasertkulChulabhorn Hospital, Bangkok, Thailand.
Waraphorn KrongthongChulabhorn Hospital, Bangkok, Thailand.
Arpaporn ArnamwongChulabhorn Hospital, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is the major cause of morbidity and mortality in Thai women. Nevertheless, the preventive strategy such as HPV vaccination program has not been implemented at the national level. This study explored the HPV prevalence and genotypic distribution in a large cohort of Thai women.

methodsA hospital-based cervical cancer screening program at Chulabhorn Hospital, Bangkok and a population-based screening program at a rural Pathum Thani Province were conducted using liquid-based cytology and HPV genotyping.

resultsOf 5906 women aged 20-70 years, Pap smear was abnormal in 4.9% and the overall HPV prevalence was 15.1%, with 6.4% high-risk (HR), 3.5% probable high-risk (PR), and 8.4% low-risk (LR) HPV. The prevalence and genotypic distribution were not significantly different between the two cohorts. Among HR-HPV genotypes, HPV52 was the most frequent (1.6%), followed by HPV16 (1.4%), HPV51 (0.9%), HPV58 (0.8%), HPV18 (0.6%), and HPV39 (0.6%). Among LR-HPV genotypes, HPV72 and HPV62 were the most frequent while HPV6 and HPV11 were rare. HPV infection was found to be proportionately high in young women, aged 20-30 years (25%) and decreasing with age (11% in women aged >50). The more severe abnormal cytology results, the higher positivity of HR-HPV infection was observed.

conclusionsIn conclusion, HPV52, HPV16, and HPV51 were identified as the most common HR-HPV genotypes in Thai women. This study contributes genotypic evidence that should be essential for the development of appropriate HPV vaccination program as part of Thailand's cervical cancer prevention strategies.

Indexed as

Cancer screeningCervical cancerCervical cytologyHPV genotypesThailand

Identifiers

PMID25737740
PMCPMC4347911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.